White Rock, British Columbia-based Invictus MD Strategies Corp. has dropped plans to list on the Nasdaq Capital Market, and a connected share consolidation.
The company applied to list its common shares on the market in January 2019.
"The intended timing of a Nasdaq uplist was premature and underway prior to my assumption of responsibilities," said CEO George Kveton, noting that the cannabis company is committed to bring its purpose-built indoor cultivation facilities into production.
The company's board expects to revisit the Nasdaq listing plan in the future.
Invictus will continue to trade on the TSX Venture Exchange under the ticker GENE, on the OTCQB Venture Market under the symbol IVITF, and on the Frankfurt Stock Exchange under the ticker 8IS2.